Identification
Personal identification
- Full name
- Sérgio Estrela Silva
Citation names
- Silva Estrela,Sergio
Author identifiers
- Ciência ID
- C519-8E6F-D6C9
- ORCID iD
- 0000-0002-7415-813X
Knowledge fields
- Medical and Health Sciences - Clinical Medicine - Ophthalmology
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
French (Mother tongue) | |||||
Portuguese (Mother tongue) | |||||
English | Elementary (A2) | Upper intermediate (B2) | Intermediate (B1) | Upper intermediate (B2) | Upper intermediate (B2) |
Education
Degree | Classification | |
---|---|---|
2006 - 2010
Concluded
|
Especialidade Oftalmologia (Título de especialista)
Universidade do Porto Faculdade de Medicina, Portugal
|
|
1995/09/01 - 2001/07/01
Concluded
|
Medicina (Licenciatura)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
Affiliation
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2016 - Current | Invited Assistant (University Teacher) | Universidade do Porto, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal |
Other Careers
Category Host institution |
Employer | |
---|---|---|
2010/03/26 - Current | Assistente graduado (Médica) | Centro Hospitalar Universitário de São João, Portugal |
Projects
Other
Designation | Funders | |
---|---|---|
2017 - Current | Participation as Principal Investigator in a SNT-IV-005 - External Natural History Controlled, Open-Label Intervention Study
to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON)
SNT-IV-005
Researcher
|
|
2011 - Current | Participation as a Sub-Investigator in a Clinical Trial phase III, Santen Study Drug 201051, Compare the efficacy and safety
of the preservative-free fixed dose combination of tafluprost 0,0015% and timolol 0,5% eye drops to those of the tafluprost
0,0015% and timolol 0,5% eye drops given concomi
Santen Study Drug 201051
Researcher
|
|
2011 - Current | MAF-AGN-OPH-GLA-010: "A 3 month, multicenter, investigator-masked, pilot study to evaluate the efficacy and safety of Bimatoprost/Timolol
fixed combination vs Latanoprost in treatment-naive patients with open-angle glaucoma at high risk of glaucomatous progression
MAF-AGN-OPH-GLA-010
Researcher
|
|
2008 - Current | Participation as a Sub-Investigator in a Clinical Trial phase III, LT2345-PIII-12/08 Efficacy and Safety assessment of T2345
unpreserved eye drops versus xalatan® in Ocular Hypertension or Glaucomatous patients.
LT2345-PIII-12/08
Researcher
|
Concluded
|
Outputs
Publications
Book chapter |
|
Journal article |
|
Activities
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2018 - Current | Doença de Stargardt e perspectivas terapêuticas
Supervisor of Tiago Paulino Fonseca Torres
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2019 - 2019 | Glaucoma e Alterações do Sistema Nervoso Central: Coincidência ou Associação?
Supervisor
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2018 - 2018 | Perspetivas de tratamento na Neuropatia Ótica de Leber
Supervisor
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2018 | Atrofia Óptica Dominante
(Thesis) Arguer
|
Rita Cristina Antunes dos Santos (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|